Home
Conditions
Graft vs Host Disease

Clinical trial condition

Graft vs Host Disease

Explore clinical trials studying Graft vs Host Disease. Study availability and eligibility vary by location and protocol.

467 public trials 74 recruiting studies

Refine in advanced search Browse all conditions

Graft vs Host Disease trial results

Recruiting

Low-Dose Liposomal Amphotericin B for Invasive Fungal Infection Prophylaxis in Neutropenic Children

NCT07725263

Conditions: Agranulocytosis, Anemia, Anemia, Hemolytic, +18 more
Locations: Haikou Affiliated Hospital of Central South University Xiangya School of Medicine Haikou, Hainan, China

View Trial Details

Recruiting

Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD

NCT06991361

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation

NCT07235501

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Hematopoietic and Lymphatic System Neoplasm, +2 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

NCT00106925

Conditions: Graft Rejection, Graft vs Host Disease, Graft-versus-leukemia, +4 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease.

NCT07708987

Conditions: GVHD - Graft-Versus-Host Disease, Graft vs Host Disease, Hematologic Diseases, +7 more
Locations: Advanced Centre for Treatment, Research and Education in Cancer Navi Mumbai, Maharashtra, India

View Trial Details

Recruiting

Evaluation of Patients With Immune Function Abnormalities

NCT00128973

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +32 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

NCT05531786

Conditions: Fibrosis, Graft vs Host Disease, Immune System Diseases, +3 more
Locations: University of Miami Miami, Florida, United States

National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCT

NCT07689630

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Hematologic Diseases, +5 more
Locations: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Recruiting

A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

NCT07359859

Conditions: Graft vs Host Disease, Hematologic Diseases, Hematologic Malignancies, +5 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States

View Trial Details

Recruiting

Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD

NCT07184853

Conditions: Graft vs Host Disease, Immune System Diseases
Locations: The First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Graft vs Host Disease

Graft vs Host Disease trial results

Related conditions